» Articles » PMID: 39898696

Implementation of Cystic Fibrosis Responsibility, Independence, Self-Care, Education Program Enhances Cystic Fibrosis Knowledge in Limited Resource Country: Results From a Randomized Controlled Trial

Abstract

Background: CF R.I.S.E is a program that helps people with Cystic Fibrosis (pwCF) transition from pediatric to adult care. In 2022, we adapted it to CF S.O.B.E in Turkish during a training session. This project aims to present the results of the CF S.O.B.E program.

Methods: This study included 81 pwCF aged 16-25, divided into two groups: the standard CF S.O.B.E. group (n = 39) and the modified group (n = 42). The standard group received face-to-face education. Both groups participated in online training sessions and received written materials. The knowledge levels were evaluated with Knowledge Assessment Questionnaires (KAQ).

Results: The standard group showed higher post-training scores in "Lung Health and Airway Clearance" and "Equipment Maintenance and Infection Control" (p = 0.014 and 0.002). Modified group showed improvements in all KAQs except "Lung Health and Airway Clearance", "CF-related Liver Disease," "Pancreatic Insufficiency and Nutrition," and "Male Sexual Health." Regarding Pancreatic Insufficiency & Nutrition and CF-related Diabetes, individuals with these conditions demonstrated higher pretest scores than those without these conditions (p = 0.01 and 0.002, respectively). Both groups and their parents reported high satisfaction, and healthcare providers endorsed the program's effectiveness.

Conclusion: Our study demonstrated the CF S.O.B.E program's success in enhancing knowledge, disease management skills, and self-confidence among pwCF. While the modified CF S.O.B.E program may be suitable for resource-limited centers, the priority should be to implement the standard program due to its superior outcomes in self-confidence and disease management. This study lays the foundation for incorporating CF S.O.B.E as a standard practice and evaluating its long-term clinical impact.

References
1.
Stephenson A, Swaleh S, Sykes J, Stanojevic S, Ma X, Quon B . Contemporary cystic fibrosis incidence rates in Canada and the United States. J Cyst Fibros. 2022; 22(3):443-449. PMC: 11214606. DOI: 10.1016/j.jcf.2022.10.008. View

2.
Baker A, Riekert K, Sawicki G, Eakin M . CF RISE: Implementing a Clinic-Based Transition Program. Pediatr Allergy Immunol Pulmonol. 2022; 28(4):250-254. DOI: 10.1089/ped.2015.0594. View

3.
Ratjen F, Doring G . Cystic fibrosis. Lancet. 2003; 361(9358):681-9. DOI: 10.1016/S0140-6736(03)12567-6. View

4.
Kirk S . Transitions in the lives of young people with complex healthcare needs. Child Care Health Dev. 2008; 34(5):567-75. DOI: 10.1111/j.1365-2214.2008.00862.x. View

5.
Burgel P, Bellis G, Olesen H, Viviani L, Zolin A, Blasi F . Future trends in cystic fibrosis demography in 34 European countries. Eur Respir J. 2015; 46(1):133-41. DOI: 10.1183/09031936.00196314. View